| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.60B | +28.7% |
| Cost of Revenue | $801.2M | +23.4% |
| R&D Expense | $1.44B | +15.2% |
| SG&A Expense | $407.5M | +4.5% |
| Operating Income | -$1.06B | +15.5% |
| Pre-tax Income | -$936.5M | +19.2% |
| Income Tax | $4.1M | +806.2% |
| Net Income | -$935.4M | +18.8% |
| EPS (Basic) | -$1.44 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $711.7M | +4.9% |
| Short-term Investments | $1.70B | +12.1% |
| Accounts Receivable | $614.8M | +21.6% |
| Current Assets | $3.73B | +13.8% |
| Total Assets | $7.18B | +16.3% |
| Current Liabilities | $3.66B | +20.0% |
| Long-term Debt | $1.21B | -3.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $822.3M | +79.5% |
| Capital Expenditures | $179.6M | -44.0% |
| Investing Cash Flow | -$852.1M | +69.8% |
| Financing Cash Flow | $65.9M | -1.9% |
| Free Cash Flow | $642.7M | +367.4% |
| +23.0% |
| EPS (Diluted) | -$1.44 | +23.0% |
| Total Liabilities |
| $6.97B |
| +14.2% |
| Stockholders' Equity | $221.4M | +190.3% |